Stem cell cornea repairing method
By simulating the corneal microenvironment and extracting stem cells in a three-dimensional dynamic culture system, combining intelligent biological scaffolds and automated regulatory systems, the problems of corneal transplant donor shortage and rejection reactions are solved, and efficient corneal repair and optimization are achieved after surgery Recover the effect.
Patent Information
- Application Number
- CN202410947847.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-16
- Publication Date
- 2024-11-22
AI Technical Summary
The existing corneal transplantation technology has problems such as donor shortage, rejection and high surgical complexity. Traditional stem cell culture methods cannot provide sufficient physiological simulation environment, resulting in low cell survival and insufficient functionality.
Stem cells were extracted using physiological extracts that simulate the corneal microenvironment, amplified in a three-dimensional dynamic culture system, designed intelligent biological scaffold materials to form multi-layer cell-scaffold complexes, and transplanted through automated regulation systems and high-resolution imaging technology Surgery, develop a personalized postoperative care plan.
It improves the accuracy and effectiveness of corneal repair, optimizes cell culture and scaffold design, significantly improves the repair effect and patient postoperative recovery, and reduces rejection and surgical trauma.
Smart Images

Figure CN118987357A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of corneal repair, and more specifically to a stem cell corneal repair method. Background Art
[0002] The cornea is the transparent front part of the eye that is responsible for focusing the light entering the eye, and its health is essential for vision. However, corneal damage or disease (such as corneal ulcers, keratitis, corneal dystrophy, etc.) can seriously affect vision and even cause blindness. Traditional corneal repair methods mainly include drug therapy and corneal transplantation. Drug therapy is generally suitable for milder corneal injuries or infections and has limited effects. Corneal transplantation is considered the most effective way to treat severe corneal damage, but it has several obvious limitations.
[0003] Currently, the main problem with corneal transplantation is the shortage of donors. Globally, the number of corneal donors is far from enough, resulting in many patients being unable to receive surgery in a timely manner. In addition, corneal transplantation surgery also has the problem of rejection, and patients may experience immune rejection after surgery, affecting the transplantation effect and postoperative recovery. Although the use of modern immunosuppressants has alleviated this problem to a certain extent, long-term use of immunosuppressants will bring other health risks.
[0004] The limitations of existing technologies have given rise to the need for new corneal repair methods. Stem cell technology has shown great potential in the field of tissue engineering and has become a new hope for corneal repair. However, corneal repair methods based on stem cells are still in the research stage and there are many technical difficulties. The in vitro culture and expansion of stem cells are the basis for achieving corneal repair, but traditional culture methods often fail to provide a sufficient physiological simulation environment, resulting in low cell survival rate and insufficient functionality. In addition, most of the existing bioscaffold materials are static and cannot dynamically respond to changes in the cell microenvironment, which limits cell growth and differentiation. For transplant surgery, existing technologies lack precise navigation and control methods, which increases the complexity and risk of surgery.
[0005] Therefore, in view of the above technical problems, it is necessary to provide a stem cell corneal repair method. Summary of the invention
[0006] The purpose of the present invention is to provide a stem cell corneal repair method to solve the above problems.
[0007] In order to achieve the above purpose, the technical solution provided by an embodiment of the present invention is as follows:
[0008] A stem cell corneal repair method, comprising the following steps:
[0009] S1. Extract stem cells from patients and donors using physiological extraction fluid that simulates the corneal microenvironment;
[0010] S2. Expand and culture the extracted stem cells in vitro in a three-dimensional dynamic culture system;
[0011] S3. Design and use of smart bio-scaffold materials;
[0012] S4. Inoculating the differentiated stem cells onto the intelligent biological scaffold material in layers to form a multi-layered cell-scaffold complex;
[0013] S5. Integrated automatic control system to monitor and control parameters in the culture environment in real time;
[0014] S6. Encapsulating the cell-scaffold complex using a biocompatible injectable material;
[0015] S7. Transplant surgery using high-resolution imaging technology and navigation system;
[0016] S8. Develop a personalized postoperative care and rehabilitation plan based on the patient's specific circumstances;
[0017] This method makes the corneal repair process more precise and effective, and can achieve efficient cell culture, optimized scaffold design and personalized care plans, thereby significantly improving the repair effect and postoperative recovery of patients.
[0018] As a further improvement of the present invention, the stem cell types in step S1 include limbal stem cells, mesenchymal stem cells or induced pluripotent stem cells. The use of multiple stem cell types can be selected according to different clinical needs and patient conditions, thereby improving the adaptability and success rate of corneal repair.
[0019] As a further improvement of the present invention, the three-dimensional dynamic culture system in step S2 includes a rotating bioreactor and a microfluidic system. The three-dimensional dynamic culture system can provide culture conditions closer to the in vivo environment and improve the cell proliferation efficiency and quality.
[0020] As a further improvement of the present invention, the intelligent bioscaffold material in step S3 includes intelligent polymers, shape memory materials and nanocomposite materials. The use of the intelligent bioscaffold material can provide better cell support and function, and promote cell differentiation and tissue regeneration.
[0021] As a further improvement of the present invention, the multilayer cell-scaffold complex in step S4 is optimized according to the different layer requirements of the cornea, and includes an epithelial cell layer, a stromal cell layer and an endothelial cell layer. The use of the layered optimized cell-scaffold complex can better simulate the structure and function of the natural cornea and improve the integration and functional recovery after transplantation.
[0022] As a further improvement of the present invention, the automated control system in step S5 includes a biosensor and a feedback control system for dynamically adjusting the oxygen concentration, pH value and temperature in the culture conditions. The automated control system can monitor and adjust the culture conditions in real time to ensure that the cells grow and differentiate in the optimal environment, thereby improving the success rate and quality of the culture.
[0023] As a further improvement of the present invention, the biocompatible injection material in step S6 is a gradually degradable hydrogel. The use of the degradable hydrogel material can provide initial support after transplantation and gradually degrade to reduce immune response, thereby improving patient acceptance and safety.
[0024] As a further improvement of the present invention, the high-resolution imaging technology in step S7 includes optical coherence tomography. The use of high-resolution imaging technology can provide accurate preoperative evaluation and intraoperative navigation, thereby improving the accuracy and success rate of the operation.
[0025] As a further improvement of the present invention, the laser-assisted technology in step S7 is used for precise positioning and reduction of surgical trauma. By utilizing laser-assisted technology, precise positioning of the transplantation site and minimally invasive operation can be achieved, surgical trauma and complications can be reduced, and the patient's postoperative recovery speed and corneal repair effect can be improved.
[0026] As a further improvement of the present invention, the personalized postoperative care and rehabilitation plan in step S8 includes a specific drug combination, regular examinations and biofeedback training, which can effectively prevent rejection reactions and infections, promote corneal healing and functional recovery, and improve the overall treatment effect and quality of life of patients.
[0027] Compared with the prior art, the advantages of the present invention are:
[0028] (1) This protocol uses physiological extracts that simulate the corneal microenvironment to extract stem cells from patients and donors to ensure their activity and functionality; the stem cells are expanded and cultured in vitro in a three-dimensional dynamic culture system to provide uniform nutrition and signal distribution and promote cell growth and differentiation; intelligent biological scaffold materials are designed and used to provide excellent mechanical support and biocompatibility; differentiated stem cells are inoculated in layers to form a multilayer cell-scaffold complex that simulates the structure of a natural cornea; an integrated automated control system is used to monitor and control key parameters in the culture environment in real time to ensure that cells grow under optimal conditions; biocompatible injectable materials are used to encapsulate the cell-scaffold complex to provide initial protection and gradual degradation; transplant surgery is performed using high-resolution imaging technology and a navigation system to ensure precise positioning and reduce trauma; finally, a personalized postoperative care and rehabilitation plan is developed based on the patient's specific situation to effectively prevent rejection and infection, promote corneal healing and functional recovery, and improve overall treatment outcomes and patient satisfaction.
[0029] (2) This protocol uses different types of stem cells such as limbal stem cells, mesenchymal stem cells or induced pluripotent stem cells, which increases the applicability and flexibility of the method; the three-dimensional dynamic culture system includes a rotating bioreactor and a microfluidic system, which can better simulate the physiological environment in the body, promote cell growth and differentiation, and improve cell functionality and survival rate; intelligent biological scaffold materials such as intelligent polymers, shape memory materials and nanocomposites improve the biocompatibility and mechanical properties of the scaffold; the multilayer cell-scaffold complex is optimized according to the needs of different levels of the cornea to improve the function and transparency of the cornea after repair; the automated control system includes biosensors and feedback control systems to ensure that cells grow under optimal conditions; the biocompatible injectable material is a gradually degradable hydrogel to reduce the long-term impact on the patient's tissues; high-resolution imaging technology such as optical coherence tomography and laser-assisted technology ensure surgical accuracy and success rate; personalized postoperative care and rehabilitation plans include specific drug combinations, regular examinations and biofeedback training to improve postoperative recovery effects and reduce the occurrence of recurrence and complications. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] Figure 1 It is a schematic diagram of the steps of the repair method of the present invention. DETAILED DESCRIPTION
[0031] The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention; it is obvious that the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments, and all other embodiments obtained by ordinary technicians in this field based on the embodiments of the present invention without making creative work are within the scope of protection of the present invention.
[0032] Embodiment 1:
[0033] See also Figure 1 , a stem cell corneal repair method, comprising the following steps:
[0034] S1. Extract stem cells from patients and donors using physiological extraction fluid that simulates the corneal microenvironment;
[0035] S2. Expand and culture the extracted stem cells in vitro in a three-dimensional dynamic culture system;
[0036] S3. Design and use of smart bio-scaffold materials;
[0037] S4. Inoculating the differentiated stem cells onto the intelligent biological scaffold material in layers to form a multi-layered cell-scaffold complex;
[0038] S5. Integrated automatic control system to monitor and control parameters in the culture environment in real time;
[0039] S6. Encapsulating the cell-scaffold complex using a biocompatible injectable material;
[0040] S7. Transplant surgery using high-resolution imaging technology and navigation system;
[0041] S8. Develop a personalized postoperative care and rehabilitation plan based on the patient's specific circumstances;
[0042] Stem cells are extracted from patients and donors using physiological extracts that simulate the corneal microenvironment to ensure their activity and functionality; stem cells are expanded and cultured in vitro in a three-dimensional dynamic culture system to provide a more uniform distribution of nutrients and signals, and promote cell growth and differentiation; intelligent biological scaffold materials are designed and used to provide excellent mechanical support and biocompatibility; differentiated stem cells are inoculated in layers to form a multilayer cell-scaffold complex to simulate the structure of a natural cornea; an integrated automated control system is used to monitor and control key parameters in the culture environment in real time to ensure that cells grow under optimal conditions; biocompatible injectable materials are used to encapsulate the cell-scaffold complex to provide initial protection and gradual degradation; transplant surgery is performed using high-resolution imaging technology and navigation systems to ensure precise positioning and reduce trauma; finally, a personalized postoperative care and rehabilitation plan is developed based on the patient's specific situation to effectively prevent rejection and infection, promote corneal healing and functional recovery, and improve overall treatment outcomes and patient satisfaction.
[0043] The stem cell types in step S1 include limbal stem cells, mesenchymal stem cells or induced pluripotent stem cells. By using different types of stem cells, the applicability and flexibility of the method are increased, and the most suitable cell type can be selected for repair according to the specific needs of different patients.
[0044] The three-dimensional dynamic culture system in step S2 includes a rotating bioreactor and a microfluidic system. The advanced three-dimensional dynamic culture system can better simulate the physiological environment in the body, promote cell growth and differentiation, and improve cell functionality and survival rate. The rotating bioreactor promotes uniform cell proliferation and vitality maintenance through a low shear environment and uniform cell distribution. The gas exchange and temperature control system ensures the stability of the culture environment. The microfluidic system uses micron-level channels and chambers to provide a highly controllable microenvironment, controls fluid flow through a pump and valve system, and uses sensors to monitor and adjust parameters such as oxygen concentration, pH value and temperature in real time to optimize cell growth conditions. Combining these two systems, the three-dimensional dynamic culture environment can simulate the physiological conditions in the body, effectively improve the proliferation efficiency and quality of stem cells, and provide high-quality cell materials for subsequent corneal repair steps.
[0045] In step S3, the intelligent biological scaffold material includes intelligent polymers, shape memory materials and nanocomposite materials. By using the intelligent biological scaffold material, the biocompatibility and mechanical properties of the scaffold are improved, which can better support cell growth and promote the structural and functional recovery of the cornea.
[0046] In step S4, the multilayer cell-scaffold complex is optimized according to the different layer requirements of the cornea, and includes an epithelial cell layer, a stromal cell layer, and an endothelial cell layer. By optimizing the cell-scaffold complex by layer, the multilayer structure of the natural cornea can be more accurately simulated, thereby improving the function and transparency of the repaired cornea.
[0047] The automated control system in step S5 includes a biosensor and a feedback control system, which are used to dynamically adjust the oxygen concentration, pH value and temperature in the culture conditions. Through the automated control system, precise control of the culture environment can be achieved to ensure that cells grow under optimal conditions and improve cell quality and repair effects.
[0048] In step S6, the biocompatible injection material is a gradually degradable hydrogel. By using a degradable hydrogel material, it can be gradually absorbed and replaced while providing initial support, thereby reducing the long-term impact on the patient's tissues.
[0049] The high-resolution imaging technology in step S7 includes optical coherence tomography. High-resolution imaging technology such as optical coherence tomography can provide detailed corneal structure images, help surgeons accurately locate and evaluate the transplant site, and significantly improve the accuracy and success rate of the operation.
[0050] In step S7, laser-assisted technology is used for precise positioning and reduction of surgical trauma. Laser-assisted technology provides high-precision cutting and positioning capabilities, reduces damage to surrounding healthy tissues during surgery, reduces the risk of postoperative complications, and promotes faster recovery.
[0051] The personalized postoperative care and rehabilitation plan in step S8 includes a specific drug combination, regular examinations and biofeedback training. The personalized postoperative care and rehabilitation plan can be adjusted and optimized according to the patient's specific situation, providing targeted drug treatment, regular examinations and rehabilitation training, thereby improving postoperative recovery effects and reducing the occurrence of recurrences and complications.
[0052] It can be seen from the above technical solutions that the present invention has the following beneficial effects:
[0053] This protocol uses physiological extracts that simulate the corneal microenvironment to extract stem cells from patients and donors to ensure their activity and functionality; the stem cells are expanded and cultured in vitro in a three-dimensional dynamic culture system to provide uniform nutrition and signal distribution to promote cell growth and differentiation; intelligent biological scaffold materials are designed and used to provide excellent mechanical support and biocompatibility; differentiated stem cells are inoculated in layers to form a multilayer cell-scaffold complex to simulate the structure of a natural cornea; an integrated automated control system is used to monitor and control key parameters in the culture environment in real time to ensure that cells grow under optimal conditions; biocompatible injectable materials are used to encapsulate the cell-scaffold complex to provide initial protection and gradual degradation; transplant surgery is performed using high-resolution imaging technology and navigation systems to ensure precise positioning and reduce trauma; finally, a personalized postoperative care and rehabilitation plan is developed based on the patient's specific situation to effectively prevent rejection and infection, promote corneal healing and functional recovery, and improve overall treatment outcomes and patient satisfaction. The use of different types of stem cells, such as limbal stem cells, mesenchymal stem cells or induced pluripotent stem cells, increases the applicability and flexibility of the method; three-dimensional dynamic culture systems include rotating bioreactors and microfluidic systems, which can better simulate the physiological environment in vivo, promote cell growth and differentiation, and improve cell functionality and survival rate; intelligent biological scaffold materials such as intelligent polymers, shape memory materials and nanocomposites improve the biocompatibility and mechanical properties of the scaffold; multilayer cell-scaffold complexes are optimized according to the needs of different levels of the cornea to enhance the function and transparency of the repaired cornea; automated control systems include biosensors and feedback control systems to ensure that cells grow under optimal conditions; biocompatible injectable materials are gradually degradable hydrogels to reduce long-term effects on patient tissues; high-resolution imaging technologies such as optical coherence tomography and laser-assisted technology ensure surgical accuracy and success rate; personalized postoperative care and rehabilitation plans include specific drug combinations, regular examinations and biofeedback training to improve postoperative recovery and reduce the occurrence of recurrence and complications.
[0054] It will be apparent to those skilled in the art that the invention is not limited to the details of the exemplary embodiments described above and that the invention can be implemented in other specific forms without departing from the spirit or essential features of the invention. Therefore, the embodiments should be considered exemplary and non-limiting in all respects, and the scope of the invention is defined by the appended claims rather than the foregoing description, and it is intended that all variations falling within the meaning and scope of the equivalent elements of the claims be included in the invention. Any reference numeral in a claim should not be considered as limiting the claim to which it relates.
[0055] In addition, it should be understood that although the present specification is described according to embodiments, not every embodiment contains only one independent technical solution. This narrative method of the specification is only for the sake of clarity. Those skilled in the art should regard the specification as a whole. The technical solutions in each embodiment may also be appropriately combined to form other implementation methods that those skilled in the art can understand.
Claims
1. A method for corneal repair using stem cells, characterized in that: The following steps are involved: S1. Extract stem cells from patients and donors using physiological extraction fluid that simulates the corneal microenvironment; S2. Expand and culture the extracted stem cells in vitro in a three-dimensional dynamic culture system; S3. Design and use of smart bio-scaffold materials; S4. Inoculating the differentiated stem cells onto the intelligent biological scaffold material in layers to form a multi-layered cell-scaffold complex; S5. Integrated automatic control system to monitor and control parameters in the culture environment in real time; S6. Encapsulating the cell-scaffold complex using a biocompatible injectable material; S7. Transplant surgery using high-resolution imaging technology and navigation system; S8. Develop an individualized postoperative care and rehabilitation plan based on the patient's specific circumstances.
2. A stem cell corneal repair method according to claim 1, characterized in that: The stem cell types in step S1 include limbal stem cells, mesenchymal stem cells or induced pluripotent stem cells.
3. A stem cell corneal repair method according to claim 1, characterized in that: The three-dimensional dynamic culture system in step S2 includes a rotating bioreactor and a microfluidic system.
4. A stem cell corneal repair method according to claim 1, characterized in that: The smart bioscaffold material in step S3 includes smart polymers, shape memory materials and nanocomposite materials.
5. A stem cell corneal repair method according to claim 1, characterized in that: The multilayer cell-scaffold complex in step S4 is optimized according to the requirements of different layers of the cornea, and includes an epithelial cell layer, a stromal cell layer and an endothelial cell layer.
6. A stem cell corneal repair method according to claim 1, characterized in that: The automated control system in step S5 includes a biosensor and a feedback control system for dynamically adjusting the oxygen concentration, pH value and temperature in the culture conditions.
7. A stem cell corneal repair method according to claim 1, characterized in that: In step S6, the biocompatible injection material is a gradually degradable hydrogel.
8. The stem cell corneal repair method according to claim 1, characterized in that: The high-resolution imaging technique in step S7 includes optical coherence tomography.
9. The stem cell corneal repair method according to claim 1, characterized in that: The laser-assisted technology in step S7 is used for precise positioning and reducing surgical trauma.
10. The stem cell corneal repair method according to claim 1, characterized in that: The personalized postoperative care and rehabilitation plan in step S8 includes a specific drug combination, regular check-ups, and biofeedback training.
